Why We Should Be Willing to Pay for Hepatitis C Treatment

類似資料

• Should we treat acute hepatitis C? A decision and cost-effectiveness analysis
  著者:: Bethea, Emily, 等
  出版事項: (2018)
• Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States
  著者:: Chhatwal, Jagpreet, 等
  出版事項: (2015)
• Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan
  著者:: Chhatwal, Jagpreet, 等
  出版事項: (2019)
• Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents
  著者:: Chen, Qiushi, 等
  出版事項: (2020)
• Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study
  著者:: Chen, Qiushi, 等
  出版事項: (2019)